We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

62 hedge funds and large institutions have $20M invested in Q32 Bio in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 17 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

975% more call options, than puts

Call options by funds: $43K | Put options by funds: $4K

0.23% less ownership

Funds ownership: 2.1% → 1.87% (-0.23%)

22% less funds holding

Funds holding: 79 → 62 (-17)

26% less capital invested

Capital invested by funds: $27.1M → $20M (-$7.13M)

47% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 17

83% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 18

Holders
62
Holders Change
-17
Holders Change %
-21.52%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
17
Closed
18
Calls
$43K
Puts
$4K
Net Calls
+$39K
Net Calls Change
-$41K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$194K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$176K
3
Bank of America
Bank of America
North Carolina
+$85.8K
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$24.5K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$15K

Top Sellers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
-$2.04M
2
OMC
Oasis Management Company
Cayman Islands
-$353K
3
Citadel Advisors
Citadel Advisors
Florida
-$287K
4
BlackRock
BlackRock
New York
-$144K
5
GCP
GSA Capital Partners
United Kingdom
-$82K
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
51
US Bancorp
Minnesota
$1.85K – – –
Osaic Holdings
52
Osaic Holdings
Arizona
$1.78K +$1.02K +41 +75%
AWM
53
Ameliora Wealth Management
Switzerland
$1.54K – – –
Simplex Trading
54
Simplex Trading
Illinois
$1K -$18.2K -730 -89%
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$1K -$75 -3 -3%
FDCDDQ
56
Federation des caisses Desjardins du Quebec
Quebec, Canada
$721 – – –
NA
57
NewEdge Advisors
Louisiana
$474 -$249 -10 -28%
BHWM
58
Beaird Harris Wealth Management
Texas
$168 – – –
IRC
59
Investors Research Corp
Georgia
$165 – – –
SIC
60
Salem Investment Counselors
North Carolina
$155 – – –
TIM
61
Thompson Investment Management
Wisconsin
$78 +$100 +4 New
ASN
62
Advisory Services Network
Georgia
$46 – – –
BG
63
Bellevue Group
Switzerland
– -$2.04M -90,140 Closed
OMC
64
Oasis Management Company
Cayman Islands
– -$353K -15,556 Closed
GCP
65
GSA Capital Partners
United Kingdom
– -$82K -3,601 Closed
Citigroup
66
Citigroup
New York
– -$78.1K -3,445 Closed
E
67
Ergoteles
New York
– -$59.1K -2,605 Closed
SCM
68
Springhouse Capital Management
Connecticut
– -$50.4K -2,222 Closed
Marshall Wace
69
Marshall Wace
United Kingdom
– -$26.2K -1,154 Closed
Jane Street
70
Jane Street
New York
– -$16.5K -727 Closed
TSS
71
Two Sigma Securities
New York
– -$16.1K -711 Closed
BAM
72
Belpointe Asset Management
Nevada
– -$3.02K -133 Closed
CA
73
Crewe Advisors
Utah
– -$1.17K -51 Closed
ACP
74
Arcus Capital Partners
Georgia
– -$968 -43 Closed
APC
75
Aspire Private Capital
North Carolina
– -$378 -17 Closed
1 2
3
4

QTTB Hedge Fund Activity: Q1 2023 in Review

62 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q1 2023, worth a combined $20M — down 26% from $27.1M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of QTTB and 3 opened new positions — a net loss of 15 holders — while 17 trimmed existing stakes and 9 added.

The largest buyer was Morgan Stanley, adding an estimated $194K. The largest seller was Bellevue Group, exiting entirely with an estimated $2.04M sold.

  • 62 institutional investors held Q32 Bio (QTTB) as of Q1 2023, down from 79 in Q4 2022.
  • Funds reported $20M of Q32 Bio stock for Q1 2023, down 26% quarter-over-quarter.
  • 3 funds opened new Q32 Bio positions in Q1 2023 and 18 closed out, a net change of -15 holders.
  • The largest Q32 Bio buyer in Q1 2023 was Morgan Stanley, an estimated $194K added.
  • The largest Q32 Bio seller in Q1 2023 was Bellevue Group, an estimated $2.04M sold.

Based on aggregated 13F filings for Q1 2023.